Corpus Intelligence IC Memo — DELAWARE COUNTY MEMORIAL HOSPITAL 2026-04-26 17:42 UTC
IC Memo — DELAWARE COUNTY MEMORIAL HOSPITAL
Investment Committee Memorandum | PA | 145 beds | Grade C | EBITDA uplift $10.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

DELAWARE COUNTY MEMORIAL HOSPITAL

CCN 390081 | nan, PA | 145 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

DELAWARE COUNTY MEMORIAL HOSPITAL is a 145-bed suburban community hospital in nan, PA with $143.5M in net patient revenue and a 1.0% operating margin. The hospital serves a payer mix of 22.2% Medicare, 6.1% Medicaid, and 71.7% commercial.

Thesis: Undervalued. Our ML models identify $10.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.0% to 8.4% (+736bps).

Net Revenue HCRIS$143.5M
Current EBITDA COMPUTED$1.5M
Operating Margin COMPUTED1.0%
Occupancy HCRIS44.3%
Revenue / Bed COMPUTED$990K
Net-to-Gross HCRIS14.7%
Distress Probability ML48.5%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
102
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 1.0% places it above the state median. Among 102 size-comparable peers (72-290 beds), the median margin is -7.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (72-290), prioritizing same-state peers. 102 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DELAWARE COUNTY MEMORIAL HOSPI (Target)PA145$143.5M1.0%
WESTERN PENNSYLVANIA HOSPITALPA255$776.4M11.1%
COMMUNITY MEDICAL CENTERPA266$474.1M3.1%
ROBERT PACKER HOSPITALPA252$471.8M-2.1%
WILLIAMSPORT HOSPITAL & MEDICAPA227$459.8M-8.4%
MOUNT NITTANY MEDICAL CENTERPA248$441.7M12.6%
MEMORIAL MEDICAL CENTERPA241$435.1M-21.2%
THE CHAMBERSBURG HOSPITALPA234$435.1M5.2%
ST LUKE HOSPITAL ANDERSON CAMPPA193$433.0M20.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.0M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$92K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.0M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.8M
A/R Days Reduction
$1.7M
Clean Claim Rate
$92K
Total EBITDA Uplift$10.6M
Current EBITDA$1.5M
+ RCM Uplift+$10.6M
Pro Forma EBITDA$12.0M
Current Margin1.0%
Pro Forma Margin8.4%
WC Released (1x)$5.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.3M$115.4M50.76x119.3%
Base (11x exit)10.0x11.0x$2.3M$127.7M56.16x123.8%
Bull Case9.0x11.0x$2.0M$163.3M79.80x140.1%
Bull (12x exit)9.0x12.0x$2.0M$178.7M87.35x144.5%
Bear Case11.0x10.0x$2.5M$61.8M24.73x90.0%
Bear (11x exit)11.0x11.0x$2.5M$68.8M27.52x94.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 102 hospitals with 72-290 beds
  • Same-state prioritization (n=103)
  • Comp margins: P25=-19.1% / P50=-7.6% / P75=5.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.